Datacise® Technology Platform

Data has never been easier to visualize.

The Datacise Dashboards really are a major step forward in exploring our Safety data.
clinical project manager
Biotechnology Sponsor (Neurology)

Datacise® is an innovative, cloud-based technology platform, that aggregates and mines data to provide real-time insights for our Sponsors.

With this secure, scalable data science platform, Datacise allows Sponsors to immediately analyze and visualize clinical data, Real-World Data (RWD) and data from other data sources through three advanced applications: Curate, Analyze, and Explore.  
 
All applications in the Datacise suite are fully integrated with the ability to use together or as stand-alone applications.

Click to learn more about Biometrics solutions that accompany this technology.


Datacise CURATE

Datacise CURATE is a flexible cloud application for the collection and aggregation of clinical data through a variety of data mapping or abstraction methods. This scalable platform simplifies the extract, load, transform (ETL) process to easily ingest structured and unstructured data from any source.

Typical Sponsor use cases for Datacise CURATE include:

  • Extract and abstract structured and unstructured data via API (application programming interfaces) or other methods
  • Build databases, including data lakes, data warehouses, and other advanced data storage structures (i.e., network graphs)
  • Harmonize data through advance pattern matching and the use of  external ontologies, including WHO Drug, MedDRA, CDISC controlled terminology, and other custom dictionaries
  • Perform data and image processing in preparation for further analysis or anonymization (DICOM images)

Datacise ANALYZE

Datacise ANALYZE supports advanced analytical needs for RWD and other data. This includes support of machine learning (ML), natural language processing (NLP) and network graphs. Several state-of-the art data science programming languages are used to analyze data, including Python, R, and  others. ANALYZE is fully integrated with other Datacise applications. Data presentations include advanced visualization features of R Shiny and JavaScript libraries for data-driven documents.

Typical Sponsor use cases for Datacise Explore include:

  • Produce simulations and scenario planning
  • Perform trend identification across disparate data, including a focus on subsets (cluster analyses)
  • Analyze data from unstructured sources, using ML and NLP
  • Ability to utilize high-performance computing as necessary for analysis

Datacise EXPLORE

https://youtu.be/TWjhlqI7r5IDatacise EXPLORE provides integrated data visualizations and dashboards to support analysis, review, and speed decision-making. This includes automated data extraction via application programming interfaces (APIs), providing direct access to a wide variety of integrated data and automated file transfers of SAS datasets and other file types. Data refreshes may be scheduled on a regular basis, and users can select between one of the numerous standards, pre-built dashboards or custom data visualizations, depending on need.

Typical Sponsor use cases for Datacise EXPLORE include:

  • DSMB (Data Safety Monitoring Boards) and Adjudication meetings including dashboards to augment static tables and listings
  • Patient profiles to aid in ongoing safety reviews and assessments
  • Dashboards for medical device and wearables data
  • In-process data reviews by clinical teams or data managers to ensure data accuracy
  • A tool used in the application of risk–based monitoring (RBM) strategies
  • Safety surveillance signal detection, using social media and regulatory data sources (i.e., FAERS)

Learn pharmaceutical industry best practices for developing practical data visualizations, tips on identifying and avoiding common pitfalls, interactive dashboards from initial discovery through UAT (User Acceptance Testing) and validation strategies, and the importance of understanding the intended audience and planned use for data visualization

Suggested For You

news

February 5th, 2026

MMS Appoints FDA Alum Dr. Somya Dunn as Senior Medical Director, Safety Risk Management to Expand Leadership in REMS and Pharmacovigilance Solutions 

perspectives

February 3rd, 2026

A Conversation with MMS Founder and CEO Dr. Uma Sharma: Building MMS: 20 Years of People-First, Data-Led Drug Development 

news

January 29th, 2026

Datacise® by MMS Named Finalist for Innovation in the Management of Clinical Data at the 2026 ACDM Awards 

ebook

January 27th, 2026

A Practical Guide to Expedited Regulatory Pathways

perspectives

January 27th, 2026

What Regulators Want to See in Surrogate Endpoints Today 

perspectives

January 20th, 2026

Behind the Scenes of Global Regulatory Submission Planning is a Symphony of Collaboration 

perspectives

January 13th, 2026

Making Clinical Trial Technology Work in Practice

fact sheet

December 17th, 2025

Advance Psychedelic Drug Development With Proven Regulatory and Data Expertise

fact sheet

December 17th, 2025

Agile Medical Writing Staff Augmentation When You Need Expertise Not Headcount

fact sheet

December 17th, 2025

Biometrics Solutions Fact Sheet: End-to-End Data Expertise for Complex Clinical Trials

whitepaper

December 17th, 2025

Estimands: Opportunity or Risk for Drug Developers?

perspectives

December 16th, 2025

Inside Pharma and Biotech’s Shifting Landscape and the Direction Leaders Are Giving for 2026